GPhA vs. PhRMA: Who Do You Believe?
This article was originally published in RPM Report
Executive Summary
The brand and generic industry release dueling studies of the competitive impact of authorized generics. Now all eyes are on an upcoming FTC report. Don't be surprised if it comes down on the side of PhRMA.